NewsRx

Search our medical news database

Cardiovascular Research

Repeated antitachycardia pacing sequences have limited efficacy

Published in Medical Devices and Surgical Technology Week, November 27th, 2005

Repeated pacing sequences provide limited benefit for atrial tachycardia (AT) patients.

"Ramp and burst pacing as treatment" for AT, a "known trigger mechanism of atrial fibrillation (AF), are available in permanent pacemakers to reduce the burden of AF," according to cardiologists in Norway, who performed an "analysis of the success rate of three consecutive antitachycardia pacing sequences."

"The AT 500 (Medtronic) pacemaker was implanted in 36 patients (18 female, mean age 77±11 years) with pacemaker indication due to tachybrady arrhythmias (n=34) and other indications (n=2)," explained P. Schuster and coauthors at the University of...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook